Board & Advisors

Board of Directors

Our Board of Directors is a group of internationally decorated Physicians, Engineers, and business leaders with strong track records of success in their respective spheres, particularly the fields of technology and diabetic care.

Advisory Panel

Orpyx Advisors rigorously review and help to elevate our corporate management, product development and clinical research. They have a wide range of expertise, with backgrounds in medicine, surgery, podiatry, business development and finance.

Dr. Robert Bray, MD, FRCSC


Dr. Robert Bray is a senior Orthopedic Surgeon at the Peter Lougheed Hospital and a Professor and Scientist of Alberta Innovates Health Solutions. His patient population includes patients with peripheral sensory deficits, athletes and lower extremity amputees. Dr. Bray has a strong background in research, has been involved extensively with medical device development, and has successfully exited previous ventures. Dr. Bray stands as a Medical Advisor and Director for Orpyx.

Dr. Breanne Everett, MD, MBA

CEO & Director

Dr. Breanne Everett is the CEO (and Director) of Orpyx, as well as a Medical Doctor and resident in the department of Plastic and Reconstructive Surgery at the University of Calgary. Seeing the burden that diabetic foot complications pose on both patients and the healthcare system, and with the goal of addressing these issues, she founded Orpyx.

David McFaul


David McFaul retired in 2010 from Boston Scientific Corporation as SVP-President-President International and a member of the Company's Executive Committee. During his 15 year tenure he was Regional President of Asia Pacific & Japan, President Japan, Vice President of Latin America, Canada and sub-Saharan Africa and responsible for the start-up and development of the Canadian business. He was the Company Chair for Worldwide Diabetes Day from 2007 to 2009. Mr. McFaul has 25 years of experience in the medical industry and is a past Board member of Covalon, a Canadian medical device company.

David Taylor, P. Eng., MBA


David Taylor is the President of Resman Holdings Ltd. an investment and venture capital company with a diverse portfolio of companies and industries. Others positions held by David include being President of Engineered Air, The Glenmore Inn and Convention Center, Airstate Ltd., Thunderstone Quarries Canmore Ltd., and Three Sisters Mountain Village Properties. David is also a director of Sabell Corporation, Stewart Creek Golf Course, Pureleau Industries Inc., Curve Dental, and Edon Management. David is also a member of the Schulich Advisory Council at the University of Calgary School of Engineering and is Chair of BOWDA (Bow Valley Builders and Developers Association).

Lew Turnquist

President & Director

Lew Turnquist has served in an advisory capacity Orpyx since 2012 and now leads its operations as the company executes its growth strategy. He has over 25 years of operational and transactional experience in technology companies. He was most recently the senior managing partner at Kirchner Private Capital Group, a US-based boutique merchant bank, where he led the firm's transactions (M&A) and operational advisory practices. Turnquist also led several early-stage technology companies including: VX Technologies Inc., J-Commerce Inc., a retail point-of-sale software company; and Cell-Loc Inc.

Dr. David G. Armstrong, DPM, MD, PhD

Principal Investigator, University of Arizona, Clinical Trials

Dr. Armstrong is Professor of Surgery (with Tenure) at The University of Arizona and Deputy Director of the Arizona Center for Accelerated Biomedical Innovation (ACABI). Dr. Armstrong holds a Masters of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He also co-founded the Southern Arizona Limb Salvage Alliance (SALSA). Armstrong was appointed Deputy Director of the Arizona Center for Accelerated Biomedical Innovation (ACABI) and co-founder of its “augmented human” initiative, which places him at the nexus of the merger of consumer electronics, wearables and medical devices. Dr. Armstrong has produced more than 420 peer-reviewed research papers in dozens of scholarly medical journals as well as over 70 book chapters. He is co-Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now entering its third edition.

Dr. Reed Ferber, PhD, CAT(C), ATC


Technical Advisor, Orpyx Medical Technologies. Director, Running Injury Clinic, University of Calgary. Dr. Reed Ferber is a board certified athletic therapist and holds a Ph.D. in sports medicine and gait biomechanics from the University of Oregon. He has completed post-doctoral research fellowships at the University of Delaware and the University of Calgary and specializes in the research and clinical treatment of lower extremity injuries. He is the Director of the Running Injury Clinic and an Assistant Professor in the Faculties of Kinesiology and Nursing at the University of Calgary. Dr. Ferber is also a Population Health Investigator through the Alberta Heritage Foundation for Medical Research.